1 May 2024 true No description of principal activity Taxfiler 2024.6 14779895 business:PrivateLimitedCompanyLtd 2024-05-01 2025-04-30 14779895 2024-04-30 14779895 business:EntityHasNeverTraded 2024-05-01 2025-04-30 14779895 2024-05-01 2025-04-30 14779895 business:AuditExempt-NoAccountantsReport 2024-05-01 2025-04-30 14779895 business:FilletedAccounts 2024-05-01 2025-04-30 14779895 2025-04-30 14779895 business:Director1 2024-05-01 2025-04-30 14779895 business:RegisteredOffice 2024-05-01 2025-04-30 14779895 2024-04-30 14779895 core:ShareCapital core:PreviouslyStatedAmount 2025-04-30 14779895 core:ShareCapital core:PreviouslyStatedAmount 2024-04-30 14779895 core:PreviouslyStatedAmount 2025-04-30 14779895 core:PreviouslyStatedAmount 2024-04-30 14779895 business:SmallEntities 2024-05-01 2025-04-30 14779895 countries:EnglandWales 2024-05-01 2025-04-30 14779895 2023-04-04 2024-04-30 iso4217:GBP xbrli:pure
Company Registration No. 14779895 (England and Wales)
INDIKA THERAPIES LIMITED Unaudited accounts for the year ended 30 April 2025
INDIKA THERAPIES LIMITED Unaudited accounts Contents
Page
Company information
3
Statement of financial position
4
Notes to the accounts
5
- 2 -
INDIKA THERAPIES LIMITED Company Information for the year ended 30 April 2025
Director
ANEELA MALLICK-FERDINAND
Company Number
14779895 (England and Wales)
Registered Office
32 HIGH MEADOW CRESCENT LONDON NW9 0XG ENGLAND
- 3 -
INDIKA THERAPIES LIMITED Statement of financial position as at 30 April 2025
2025
2024
Notes
£
£
Current assets
Cash at bank and in hand
1
1
Net current assets
1
1
Net assets
1
1
Capital and reserves
Called up share capital
1
1
Shareholders' funds
1
1
For the year ending 30 April 2025 the company was entitled to exemption from audit under section 480 of the Companies Act 2006 relating to dormant companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 5 November 2025 and were signed on its behalf by
ANEELA MALLICK-FERDINAND Director Company Registration No. 14779895
- 4 -
INDIKA THERAPIES LIMITED Notes to the Accounts for the year ended 30 April 2025
1
Statutory information
INDIKA THERAPIES LIMITED is a private company, limited by shares, registered in England and Wales, registration number 14779895. The registered office is 32 HIGH MEADOW CRESCENT, LONDON, NW9 0XG, ENGLAND.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling.
4
Average number of employees
During the year the average number of employees was 0 (2024: 0).
- 5 -